نتایج جستجو برای: suvorexant

تعداد نتایج: 122  

Journal: :Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2017
Michael J Sateia Daniel J Buysse Andrew D Krystal David N Neubauer Jonathan L Heald

INTRODUCTION The purpose of this guideline is to establish clinical practice recommendations for the pharmacologic treatment of chronic insomnia in adults, when such treatment is clinically indicated. Unlike previous meta-analyses, which focused on broad classes of drugs, this guideline focuses on individual drugs commonly used to treat insomnia. It includes drugs that are FDA-approved for the ...

Journal: :Psychiatry and clinical neurosciences reports 2023

Benzodiazepine hypnotics (BZDs) have been a popular treatment for insomnia since the 1960s, but they various problematic side effects, including falls and delirium.1, 2 Non-BZDs were developed right after BZDs are BZD receptor agonists (BZD-RAs) in action. In Japan, two other non-BZD-RA released, namely ramelteon (melatonin agonist [MRA]) 2010 suvorexant (orexin antagonist [ORA]) 2014. Despite ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید